CIK 0001787400
- Non-accelerated filer
- Smaller reporting company
Nkarta, Inc.
Sign in to watch- Ticker
- NKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474515206
- Phone
- +1 925-407-1049
- Business address
- 1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Medical Officer sold 439 shares at $4.85 ($2,129)
- 4 Open-market sale Mahmood Nadir sold 526 shares at $4.85 ($2,551)
- 4 Open-market sale Chief Executive Officer sold 1,704 shares at $4.85 ($8,264)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 1,115 shares at $5.49 ($6,121)
- 4 Open-market sale Chief Medical Officer sold 175 shares at $5.49 ($961)
- 4 Open-market sale Mahmood Nadir sold 1,122 shares at $5.49 ($6,160)
- 4 Open-market sale Chief Executive Officer sold 3,691 shares at $5.49 ($20,264)
- 4 Open-market sale Chief Legal Officer sold 1,103 shares at $5.49 ($6,055)
- 4 Open-market sale Chief Technical Officer sold 491 shares at $5.49 ($2,696)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Technical Officer sold 842 shares at $14.02 ($11,805)
- 4 Open-market sale Chief Executive Officer sold 23,874 shares at an average $13.03 ($311,089)
Page 5 of 11 · 218 filings